Skip to search formSkip to main contentSkip to account menu

ecabapide

Known as: 3-2-2-(3,4-dimethoxyphenyl)ethylamino-2-oxoethylamino-N-methylbenzamide, Benzamide, 3-((2-((2-(3,4-dimethoxyphenyl)ethyl)amino)-2-oxoethyl)amino)-N-methyl- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The airway response to deep inspirations (DIs) in asthmatics has been shown to be ineffective in producing bronchodilation and… 
1999
1999
1. In vitro studies identified the hepatic cytochrome P450 (CYP) enzyme(s) involved in the major metabolism of ecabapide in human… 
1997
1997
A facile detrifluoromethylation was observed when 4,4-bis(trifluoromethyl)-5-hydroxyimidazoline 5 was treated with a variety of… 
Review
1997
Review
1997
The pharmacology of ecabapide (DQ‐2511; 3‐[2‐(3,4‐dimethoxyphenyl)ethylcarbamoylmethyl]amino‐N‐methylbenzamide) is reviewed. 
1996
1996
1 The membrane potential of rabbit gastric parietal cells is dominated by a Cl− channel with a sub‐picosiemens single channel… 
1990
1990
Effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl] methyl]-amino-N-methylbenzamide (DQ-2511), a newly synthesized compound… 
Highly Cited
1977
Highly Cited
1977
Papain is strongly inhibited by aldehydes resembling carboxylic acids, released by hydrolysis of specific substrates (Westerik, J…